economybharat.com

We Can Cover You
Click here
Facebook Youtube Instagram Linkedin
13
13

Equity

US-listed company intends to make an offer to take over a minimum of 51% of the shares in DecideAct A/S and has signed LOI

US-listed company intends to make an offer to take over a minimum of 51% of the shares in DecideAct A/S and has signed LOI

creativebharatgroup@gmail.com November 14, 2024
DecideAct A/S [ACT] NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN DecideAct A/S (the Company) has signed...
Read More Read more about US-listed company intends to make an offer to take over a minimum of 51% of the shares in DecideAct A/S and has signed LOI
PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen OG_Companylog_92449.jpg

PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen

creativebharatgroup@gmail.com November 14, 2024
MUMBAI, India & HYDERABAD, India:  PopVax, an Indian full-stack biotechnology company developing novel...
Read More Read more about PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen